Academic Unit for Ageing and Stroke Research (University of Leeds), Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
BMJ. 2024 Mar 21;384:e077764. doi: 10.1136/bmj-2023-077764.
To synthesise evidence of the effectiveness of community based complex interventions, grouped according to their intervention components, to sustain independence for older people.
Systematic review and network meta-analysis.
Medline, Embase, CINAHL, PsycINFO, CENTRAL, clinicaltrials.gov, and International Clinical Trials Registry Platform from inception to 9 August 2021 and reference lists of included studies.
Randomised controlled trials or cluster randomised controlled trials with ≥24 weeks' follow-up studying community based complex interventions for sustaining independence in older people (mean age ≥65 years) living at home, with usual care, placebo, or another complex intervention as comparators.
Living at home, activities of daily living (personal/instrumental), care home placement, and service/economic outcomes at 12 months.
Interventions were grouped according to a specifically developed typology. Random effects network meta-analysis estimated comparative effects; Cochrane's revised tool (RoB 2) structured risk of bias assessment. Grading of recommendations assessment, development and evaluation (GRADE) network meta-analysis structured certainty assessment.
The review included 129 studies (74 946 participants). Nineteen intervention components, including "multifactorial action from individualised care planning" (a process of multidomain assessment and management leading to tailored actions), were identified in 63 combinations. For living at home, compared with no intervention/placebo, evidence favoured multifactorial action from individualised care planning including medication review and regular follow-ups (routine review) (odds ratio 1.22, 95% confidence interval 0.93 to 1.59; moderate certainty); multifactorial action from individualised care planning including medication review without regular follow-ups (2.55, 0.61 to 10.60; low certainty); combined cognitive training, medication review, nutritional support, and exercise (1.93, 0.79 to 4.77; low certainty); and combined activities of daily living training, nutritional support, and exercise (1.79, 0.67 to 4.76; low certainty). Risk screening or the addition of education and self-management strategies to multifactorial action from individualised care planning and routine review with medication review may reduce odds of living at home. For instrumental activities of daily living, evidence favoured multifactorial action from individualised care planning and routine review with medication review (standardised mean difference 0.11, 95% confidence interval 0.00 to 0.21; moderate certainty). Two interventions may reduce instrumental activities of daily living: combined activities of daily living training, aids, and exercise; and combined activities of daily living training, aids, education, exercise, and multifactorial action from individualised care planning and routine review with medication review and self-management strategies. For personal activities of daily living, evidence favoured combined exercise, multifactorial action from individualised care planning, and routine review with medication review and self-management strategies (0.16, -0.51 to 0.82; low certainty). For homecare recipients, evidence favoured addition of multifactorial action from individualised care planning and routine review with medication review (0.60, 0.32 to 0.88; low certainty). High risk of bias and imprecise estimates meant that most evidence was low or very low certainty. Few studies contributed to each comparison, impeding evaluation of inconsistency and frailty.
The intervention most likely to sustain independence is individualised care planning including medicines optimisation and regular follow-up reviews resulting in multifactorial action. Homecare recipients may particularly benefit from this intervention. Unexpectedly, some combinations may reduce independence. Further research is needed to investigate which combinations of interventions work best for different participants and contexts.
PROSPERO CRD42019162195.
综合社区为基础的复杂干预措施的有效性证据,根据其干预措施的组成部分进行分组,以维持老年人的独立性。
系统评价和网络荟萃分析。
从创建到 2021 年 8 月 9 日,在 Medline、Embase、CINAHL、PsycINFO、CENTRAL、clinicaltrials.gov 和国际临床试验注册平台上搜索,并查阅纳入研究的参考文献列表。
具有≥24 周随访的社区为基础的复杂干预措施的随机对照试验或整群随机对照试验,以维持居住在家中的老年人(平均年龄≥65 岁)的独立性,对照组为常规护理、安慰剂或另一种复杂干预措施。
12 个月时的居家生活、日常生活活动(个人/工具性)、入住养老院和服务/经济结局。
根据专门制定的分类法对干预措施进行分组。随机效应网络荟萃分析估计了相对效果;Cochrane 修订工具(RoB 2)对风险偏倚进行结构化评估。推荐评估、制定和评价(GRADE)网络荟萃分析对确定性进行结构化评估。
综述纳入了 129 项研究(74946 名参与者)。确定了 19 个干预组成部分,包括“个体化护理计划的多因素行动”(一种多维评估和管理导致量身定制的行动的过程),共 63 种组合。与无干预/安慰剂相比,对于居家生活,个体化护理计划中包含药物审查和定期随访(常规审查)(优势比 1.22,95%置信区间 0.93 至 1.59;中等确定性);个体化护理计划中包含药物审查但无定期随访(2.55,0.61 至 10.60;低确定性);认知训练、药物审查、营养支持和运动相结合(1.93,0.79 至 4.77;低确定性);以及日常生活活动训练、营养支持和运动相结合(1.79,0.67 至 4.76;低确定性)可能更有利于居家生活。风险筛查或在个体化护理计划和药物审查的常规审查中添加教育和自我管理策略,可能会降低居家生活的可能性。对于工具性日常生活活动,个体化护理计划和药物审查的常规审查证据支持(标准化均数差 0.11,95%置信区间 0.00 至 0.21;中等确定性)。有两种干预措施可能会降低工具性日常生活活动:日常生活活动训练、辅助器具和运动相结合;以及日常生活活动训练、辅助器具、教育、运动、个体化护理计划和药物审查以及自我管理策略相结合。对于个人日常生活活动,证据支持结合运动、个体化护理计划和药物审查的常规审查以及自我管理策略(0.16,-0.51 至 0.82;低确定性)。对于需要护理的人,证据支持在个体化护理计划和药物审查的常规审查中添加多因素行动(0.60,0.32 至 0.88;低确定性)。高风险偏倚和不精确的估计意味着大多数证据为低或极低确定性。很少有研究对每一项比较做出贡献,这妨碍了对不一致性和脆弱性的评估。
最有可能维持独立性的干预措施是个体化护理计划,包括药物优化和定期随访审查,从而产生多因素行动。需要护理的人可能特别受益于这种干预措施。出乎意料的是,一些组合可能会降低独立性。需要进一步研究,以调查哪些干预措施组合对不同的参与者和环境最有效。
PROSPERO CRD42019162195。